ERBB2 and lung carcinoma: Previous reports have identified germline mutations in driver oncogenes that are associated with lung cancers, such as EGFR32–36 and human epidermal growth factor receptor 2 (HER2)37, which suggests that a heritable predisposition to lung cancer is a contributor in some cases.